Skip to content
GLP Loss
Head to head

Edessa vs Idgie Health

Idgie's tablet carries a second drug its price card never names, so part of the $58 between these two is buying a different formulation.

By Hana BrennanPricing & provider data

Edessa

Editorial

$229/mo

Injectable semaglutide from $179 with an oral option at $229, and tirzepatide at $239. One of the few sellers here where the oral price sits between the two injectables rather than above both.

  • Publishes the full plan table rather than one headline figure
  • Oral and injectable priced separately and openly
  • Price holds as the dose climbs
  • Fifty-one states
  • The homepage figure is the six-month rate, not the monthly one
  • Month-to-month costs $44 more than the number on the front page
  • The oral tablet is $50 dearer than the injection, not cheaper

Pick it for: A plain tablet, cheapest if you commit six months

Not for: Anyone wanting to try a month and stop. The month-to-month price is the one to compare, and it is not the advertised one.

Idgie Health

Editorial

$287/mo

Semaglutide is $134 injected and $287 orally — more than double for the tablet. Oral GLP-1s are routinely marketed as the accessible option, and this is a clear case where the needle is the cheaper one.

  • Publishes separate prices for oral and injectable rather than one figure
  • Describes microdosing as off-label rather than implying it is standard
  • Price holds across the titration ladder
  • Three-month rates shown alongside monthly
  • The oral tablet costs more than twice the injection
  • The oral formulation includes a second drug, which the headline does not say
  • Tirzepatide is only offered by injection

Pick it for: A tablet with the nausea drug already in it

Not for: Anyone who came to oral GLP-1s looking to save money. The injection is the cheaper product here by a wide margin.

Our verdict

Idgie's oral is a semaglutide and ondansetron dissolving tablet, an anti-nausea drug inside the dose, named on the program menu and nowhere near the price. Edessa's tablet is plain compounded semaglutide. Both cut the figure for a term, to $199 a month at Edessa on six months and $249 at Idgie on three, and neither figure is re-priced at a higher dose.

What actually separates them

Edessa and Idgie Health differ on published price and where you can use it. The table summarizes those terms; confirm any details it does not cover with the provider.

Idgie Health’s comparison figure is $58 higher than Edessa’s — a 25% difference between the listed rates. These figures do not establish equivalent prescribed doses, supply or care. Confirm the selected product, full payment obligation and next charge.

At unchanged rates, a twelve-month illustration is about $2,748 at Edessa against $3,444 at Idgie Health — a difference of $696. This is not a quote for a year of care: actual charges depend on prescribed supply, purchase terms and renewals.

 EdessaIdgie Health
Published price$229/mo$287/mo
Where you can use it51 states50 states

What neither of them tells you

A comparison that only reports differences implies everything else is settled. Here it is not.

  • Neither publishes a milligram dose, so neither price can be compared with the other — or with anything else.

Before you choose either

The providers describe different service areas. Edessa lists 1 state that Idgie Health does not list — DC. Confirm your location and selected medication directly. A provider-wide footprint does not establish every treatment’s availability.

Neither of these sellers publishes a milligram dose, so neither price can be compared with the other or with anything else — which is normal in this category and is exactly the problem. Ask both what dose the monthly price buys, and see the sellers that do publish one before you assume the cheaper sticker is the cheaper product.

Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.

All head-to-head comparisons · The full injections ranking